Role of Inhaled Albuterol in the Management of Transient Tachypnea of Newborn
DOI:
https://doi.org/10.70749/ijbr.v3i2.617Keywords:
Inhaled Albuterol, Transient Tachypnea, Newborn, NeonatesAbstract
Transient tachypnea of newborns (TTN) is the most common cause of respiratory distress in neonates. Objectives: The objective of this study is to compare the mean TTN score in the inhaled albuterol VS placebo group in addition to standard treatment in patients with Transient tachypnea of newborns. Material and Methods: This randomized control trial (RCT) was conducted in the In-Patient Department of Pediatrics Medicine at Shalamar Hospital, Lahore. Data were collected from 60 patients (30 in each group) by using a random and unbiased selection of participants into treatment and control groups. Results: Albuterol group, 60% of the neonates were male and 40% were female, compared to 55% male and 45% female in the Placebo group. The mean birth weight in the Albuterol group was slightly higher at 3.2 ± 0.3 kg compared to 3.1 ± 0.2 kg in the Placebo group. The mean gestational age was similar between the groups, with 38.5 ± 1.2 weeks in the Albuterol group and 38.4 ± 1.1 weeks in the Placebo group. A higher percentage of neonates in both groups were delivered via C-section, with 65% in the Albuterol group and 60% in the Placebo group. Albuterol group had a significant reduction in TTN score from a baseline of 6.5 ± 0.5 to 2.1 ± 0.4 after 4 hours, while the Placebo group had a smaller reduction from 6.4 ± 0.4 to 4.8 ± 0.6. In terms of tachypnea resolution, 60% of neonates in the Albuterol group recovered within 12 hours, compared to only 20% in the Placebo group. Conclusion: It is concluded that inhaled albuterol is an effective and safe treatment for managing transient tachypnea in the newborn. The use of albuterol significantly reduces respiratory distress and accelerates symptom resolution compared to placebo.
Downloads
References
Mohammadzadeh, I., Akbarian-Rad, Z., Heidari, F., Zahedpasha, Y., & Haghshenas-Mojaveri, M. (2017). The effect of inhaled salbutamol in transient of tachypnea of the newborn: A randomized clinical trial. Iranian Journal of Pediatrics, 27(5). https://doi.org/10.5812/ijp.9633
Al, D. M., Elsayed, H. M., & Mohammed, I. S. (2020). The effects of inhaled β-adrenergic agonists in transient tachypnea of the newborn. Menoufia Medical Journal /Menoufia Medical Journal, 33(3), 847. https://doi.org/10.4103/mmj.mmj_320_18
Maroof, F., Maqbool, T., Irfan, H. M., Mughal, B. B., -, A., -, N., & Ahsan, M. (2021). Salbutamol nebulization for management of transient tachypnea of newborn (TTN). The Professional Medical Journal, 28(01), 52-59. https://doi.org/10.29309/tpmj/2021.28.01.4614
Talaat, A. A., Abohashish, M. M., Farid, T. M., & Salah, M. M. (2020). Evaluation of inhaled beta-2 agonist in management of transient tachypnea of the newborn. Bulletin of the National Research Centre, 44(1). https://doi.org/10.1186/s42269-020-0271-y
Sabry, A. M., Azeem, M. A., Ismail, M. M., El Khatib, D. H., & AbdelAziz, I. A. (2022). Comparison of inhaled salbutamol and intravenous furosemide in the treatment of transient tachypnea of the newborn regarding their safety and efficacy. Alexandria Journal of Pediatrics, 35(2), 92-98. https://doi.org/10.4103/ajop.ajop_22_22
Khushdil, A., Ahmed, Z., Ahmed, M., Nazir, S., & Waqar, T. (2022). Effects of salbutamol and Furosemide in the treatment of transient tachypnea of newborn - A randomized controlled trial. Pakistan Armed Forces Medical Journal, 72(1), 101-04. https://doi.org/10.51253/pafmj.v72i1.6076
Mussavi, M., Asadollahi, K., Kayvan, M., & Sadeghvand, S. (2017). Effects of nebulized Albuterol in transient tachypnea of the newborn a clinical trial. Iranian Journal of Pediatrics, 27(3). https://doi.org/10.5812/ijp.8211
El-Badawy, A. M., M. Ibrahim, A., M. El-Mashad, A. E., & M. Awny, M. (2021). Efficacy of Budesonide, epinephrine and salbutamol inhalation for treatment of transient tachypnea of newborn: Prospective controlled study. Asian Journal of Pediatric Research, 10-19. https://doi.org/10.9734/ajpr/2021/v7i330217
Malakian, A., Dehdashtian, M., Aramesh, M. R., Aletayeb, M. H., & Heidari, S. (2018). The effect of inhaled salbutamol on the outcomes of transient tachypnea of the newborn. Journal of the Chinese Medical Association, 81(11), 990-997. https://doi.org/10.1016/j.jcma.2018.01.015
salama, A., El-Seheim), L., & Elsamanoudy, M. (2020). Inhaled salbutamol for the treatment of transient tachypnea of the newborn. International Journal of Medical Arts, 0(0), 0-0. https://doi.org/10.21608/ijma.2020.21436.1064
Alhassen, Z., Vali, P., Guglani, L., Lakshminrusimha, S., & Ryan, R. M. (2020). Recent advances in pathophysiology and management of transient tachypnea of newborn. Journal of Perinatology, 41(1), 6-16. https://doi.org/10.1038/s41372-020-0757-3
Basiri, B., Sadeghi, N., Sabzehei, M. K., & Ashari, F. E. (2021). Effects of inhaled salbutamol on transient tachypnea of the newborn. Respiratory Care, 67(4), 433-439. https://doi.org/10.4187/respcare.09284
Malakian, A., Dehdashtian, M., Aramesh, M. R., Aletayeb, M. H., & Heidari, S. (2018). The effect of inhaled salbutamol on the outcomes of transient tachypnea of the newborn. Journal of the Chinese Medical Association, 81(11), 990-997. https://doi.org/10.1016/j.jcma.2018.01.015
Goudarzi, R. M., Badiee, Z., Sadeghnia, A., & Barekatain, B. (2023). Evaluation of intratracheal salbutamol effects in addition to surfactant in the clinical course of premature neonates with respiratory distress syndrome. Journal of Research in Medical Sciences, 28(1). https://doi.org/10.4103/jrms.jrms_548_22
Buchiboyina, A., Jasani, B., Deshmukh, M., & Patole, S. (2016). Strategies for managing transient tachypnoea of the newborn - a systematic review. The Journal of Maternal-Fetal & Neonatal Medicine, 30(13), 1524-1532. https://doi.org/10.1080/14767058.2016.1193143
Nakhshab, M., Tajbakhsh, M., Khani, S., & Farhadi, R. (2015). Comparison of the effect of surfactant administration during nasal continuous positive airway pressure with that of nasal continuous positive airway pressure alone on complications of respiratory distress syndrome: A randomized controlled study. Pediatrics & Neonatology, 56(2), 88-94. https://doi.org/10.1016/j.pedneo.2014.05.006
Koh, J. W., Kim, J., & Chang, Y. P. (2018). Transient intubation for surfactant administration in the treatment of respiratory distress syndrome in extremely premature infants. Korean Journal of Pediatrics, 61(10), 315-321. https://doi.org/10.3345/kjp.2018.06296
Mussavi, M., Asadollahi, K., Kayvan, M., & Sadeghvand, S. (2017). Effects of nebulized Albuterol in transient tachypnea of the newborn a clinical trial. Iranian Journal of Pediatrics, 27(3). https://doi.org/10.5812/ijp.8211
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Indus Journal of Bioscience Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
